Triptorelin Acetate — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

5 Recruiting

3 Completed trials

10 Sponsors

15 Countries

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 5 Phase II: 2 Phase III/IV: 1 Phase IV: 2

Oversight events:

2 unexpected events across 1 trial

View oversight register →

Indications tested

Hormone-dependent prostate cancer 1 Prostate cancer 1

Sponsors using this IMP

European Organisation For Research And Treatment Of Cancer 2 ARTIC 1 Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi 1 Ferring Pharmaceuticals A/S 1 Medica Scientia Innovation Research S.L. 1 Novartis Pharma AG 1 Solti Group 1 Stemline Therapeutics Inc. 1 Universitair Ziekenhuis Gent 1 UZ Brussel 1

All trials

10 total

MENOPUR and REKOVELLE in Women UnderGoing an assisted reproductive technology cycle Pending

2022-500308-23-00 Phase III/IV 2 countries Ferring Pharmaceuticals A/S
ALADDIN: evaluation of dAroLutamide Addition to anDrogen Deprivation therapy and radIatioN therapy in newly diagnosed prostate cancer with p… Pending

2024-517285-41-00 Phase III 1 country ARTIC
A randomized phase 3, double-blind, placebo-controlled study of elacestrant plus everolimus versus elacestrant in patients with estrogen rec… Recruiting

2024-512926-27-00 Phase III 7 countries Medica Scientia Innovation Research S.L.; Stemline Therapeutics Inc.
EORTC-2238-GUCG: Improving impact of anti-androgen treatments on patient's daily life and their cancer Recruiting

2023-506817-23-01 Phase III 9 countries European Organisation For Research And Treatment Of Cancer
RAndom sTArT Ovarian stimUlatIon (RSOS) in eLective oocyte cryopreservation cycLEs (RATATOUILLE): a single-center, non-inferiority, randomis… Recruiting

2023-509919-89-00 Phase IV 1 country UZ Brussel
PPOS (Progestin primed ovarian stimulation) and Corifollitropin alfa (CFA) cross-over study Recruiting

2023-506694-35-00 Phase IV 1 country Universitair Ziekenhuis Gent
Phase II, multicenter, randomized, open-label study of premenopausal women with luminal breast cancer investigating the effect of elacestran… Recruiting

2023-503373-37-01 Phase II 1 country Solti Group
An Open-label study comparing 177Lu-PSMA-617 plus Standard of Care vs. Standard of Care in the Treatment of mHSPC Ended

2023-507970-42-00 Phase III 10 countries Novartis Pharma AG
Darolutamide vs ADT in hormone naïve Pca Ended

2024-510840-30-00 Phase II 4 countries European Organisation For Research And Treatment Of Cancer
A research study to compare the standard treatment and the study drug (degarelix) in combination with radiotherapy in patients with high-ris… Ended

2024-513450-30-00 Phase III 3 countries Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europ…

Showing 1–10 of 10 trials

← All drugs A–Z